ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

ACS announces 415 New Awards

August 31, 1979

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003

NCI-Approved Clinical Trials Listed For January

January 28, 2005

New Grants Awarded In Tobacco Research

February 17, 1978

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

NCI RFAs Available

May 5, 2000